Boston Therapeutics' Affiliate Advance Pharmaceutical Company Progresses with BTI-320 Clinical Trial Life Science Investing
Immunovaccine and PharmAthene Sign License Agreement to Develop and Commercialize an Anthrax Vaccine Life Science Investing